nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCB1—Naltrexone—alcohol dependence	0.162	0.602	CbGbCtD
Afatinib—ABCB1—Citalopram—alcohol dependence	0.108	0.398	CbGbCtD
Afatinib—Dermatitis acneiform—Disulfiram—alcohol dependence	0.0331	0.0999	CcSEcCtD
Afatinib—Dermatitis acneiform—Citalopram—alcohol dependence	0.00976	0.0295	CcSEcCtD
Afatinib—PHKG2—brainstem—alcohol dependence	0.00705	0.0239	CbGeAlD
Afatinib—HIPK4—gonad—alcohol dependence	0.00685	0.0232	CbGeAlD
Afatinib—Rhinorrhoea—Naltrexone—alcohol dependence	0.0065	0.0196	CcSEcCtD
Afatinib—ERBB4—brainstem—alcohol dependence	0.00634	0.0215	CbGeAlD
Afatinib—ERBB4—forebrain—alcohol dependence	0.00612	0.0208	CbGeAlD
Afatinib—DYRK1A—brainstem—alcohol dependence	0.0061	0.0207	CbGeAlD
Afatinib—BLK—blood—alcohol dependence	0.00597	0.0202	CbGeAlD
Afatinib—DYRK1A—forebrain—alcohol dependence	0.00589	0.02	CbGeAlD
Afatinib—EPHA6—gonad—alcohol dependence	0.00541	0.0184	CbGeAlD
Afatinib—PHKG2—gonad—alcohol dependence	0.00522	0.0177	CbGeAlD
Afatinib—HIPK4—endocrine gland—alcohol dependence	0.00518	0.0176	CbGeAlD
Afatinib—ERBB4—cardiovascular system—alcohol dependence	0.00517	0.0175	CbGeAlD
Afatinib—ERBB2—cardiovascular system—alcohol dependence	0.00517	0.0175	CbGeAlD
Afatinib—Keratitis—Citalopram—alcohol dependence	0.00514	0.0155	CcSEcCtD
Afatinib—Mouth ulceration—Acamprosate—alcohol dependence	0.00503	0.0152	CcSEcCtD
Afatinib—ERBB2—pancreas—alcohol dependence	0.00503	0.0171	CbGeAlD
Afatinib—DYRK1A—cardiovascular system—alcohol dependence	0.00498	0.0169	CbGeAlD
Afatinib—HIPK4—testis—alcohol dependence	0.00494	0.0167	CbGeAlD
Afatinib—ERBB2—gonad—alcohol dependence	0.00469	0.0159	CbGeAlD
Afatinib—DYRK1A—gonad—alcohol dependence	0.00452	0.0153	CbGeAlD
Afatinib—ERBB2—digestive system—alcohol dependence	0.00429	0.0146	CbGeAlD
Afatinib—Rhinorrhoea—Citalopram—alcohol dependence	0.00412	0.0124	CcSEcCtD
Afatinib—EPHA6—endocrine gland—alcohol dependence	0.00409	0.0139	CbGeAlD
Afatinib—ERBB2—blood—alcohol dependence	0.00409	0.0139	CbGeAlD
Afatinib—ERBB4—midbrain—alcohol dependence	0.00404	0.0137	CbGeAlD
Afatinib—PHKG2—endocrine gland—alcohol dependence	0.00395	0.0134	CbGeAlD
Afatinib—EPHA6—testis—alcohol dependence	0.0039	0.0132	CbGeAlD
Afatinib—EPHA6—nervous system—alcohol dependence	0.00383	0.013	CbGeAlD
Afatinib—PHKG2—testis—alcohol dependence	0.00376	0.0128	CbGeAlD
Afatinib—IRAK1—pancreas—alcohol dependence	0.00376	0.0128	CbGeAlD
Afatinib—HIPK4—brain—alcohol dependence	0.0037	0.0126	CbGeAlD
Afatinib—Dry skin—Acamprosate—alcohol dependence	0.0037	0.0112	CcSEcCtD
Afatinib—PHKG2—nervous system—alcohol dependence	0.00369	0.0125	CbGeAlD
Afatinib—EPHA6—central nervous system—alcohol dependence	0.00369	0.0125	CbGeAlD
Afatinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00364	0.011	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00356	0.0108	CcSEcCtD
Afatinib—PHKG2—liver—alcohol dependence	0.00356	0.0121	CbGeAlD
Afatinib—PHKG2—central nervous system—alcohol dependence	0.00356	0.0121	CbGeAlD
Afatinib—Dehydration—Naltrexone—alcohol dependence	0.00355	0.0107	CcSEcCtD
Afatinib—ERBB2—endocrine gland—alcohol dependence	0.00355	0.012	CbGeAlD
Afatinib—ERBB4—endocrine gland—alcohol dependence	0.00355	0.012	CbGeAlD
Afatinib—PHKG2—cerebellum—alcohol dependence	0.00348	0.0118	CbGeAlD
Afatinib—Fatigue—Disulfiram—alcohol dependence	0.00347	0.0105	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00344	0.0104	CcSEcCtD
Afatinib—Nasopharyngitis—Naltrexone—alcohol dependence	0.00342	0.0103	CcSEcCtD
Afatinib—DYRK1A—endocrine gland—alcohol dependence	0.00342	0.0116	CbGeAlD
Afatinib—ERBB2—testis—alcohol dependence	0.00338	0.0115	CbGeAlD
Afatinib—ERBB4—testis—alcohol dependence	0.00338	0.0115	CbGeAlD
Afatinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00337	0.0102	CcSEcCtD
Afatinib—ERBB2—nervous system—alcohol dependence	0.00332	0.0113	CbGeAlD
Afatinib—ERBB4—nervous system—alcohol dependence	0.00332	0.0113	CbGeAlD
Afatinib—Cystitis noninfective—Citalopram—alcohol dependence	0.00326	0.00985	CcSEcCtD
Afatinib—DYRK1A—testis—alcohol dependence	0.00326	0.011	CbGeAlD
Afatinib—Cystitis—Citalopram—alcohol dependence	0.00322	0.00973	CcSEcCtD
Afatinib—ERBB2—liver—alcohol dependence	0.0032	0.0109	CbGeAlD
Afatinib—ERBB4—central nervous system—alcohol dependence	0.0032	0.0108	CbGeAlD
Afatinib—ERBB2—central nervous system—alcohol dependence	0.0032	0.0108	CbGeAlD
Afatinib—DYRK1A—nervous system—alcohol dependence	0.0032	0.0108	CbGeAlD
Afatinib—Weight decreased—Acamprosate—alcohol dependence	0.00316	0.00954	CcSEcCtD
Afatinib—Pneumonia—Acamprosate—alcohol dependence	0.00313	0.00946	CcSEcCtD
Afatinib—ERBB2—cerebellum—alcohol dependence	0.00313	0.0106	CbGeAlD
Afatinib—ERBB4—cerebellum—alcohol dependence	0.00313	0.0106	CbGeAlD
Afatinib—Dry eye—Citalopram—alcohol dependence	0.00308	0.00931	CcSEcCtD
Afatinib—DYRK1A—liver—alcohol dependence	0.00308	0.0104	CbGeAlD
Afatinib—DYRK1A—central nervous system—alcohol dependence	0.00308	0.0104	CbGeAlD
Afatinib—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00307	0.00928	CcSEcCtD
Afatinib—IRAK1—blood—alcohol dependence	0.00306	0.0104	CbGeAlD
Afatinib—Stomatitis—Acamprosate—alcohol dependence	0.00303	0.00917	CcSEcCtD
Afatinib—Urinary tract infection—Acamprosate—alcohol dependence	0.00303	0.00914	CcSEcCtD
Afatinib—IRAK1—midbrain—alcohol dependence	0.00302	0.0102	CbGeAlD
Afatinib—Bladder pain—Citalopram—alcohol dependence	0.00302	0.00911	CcSEcCtD
Afatinib—Mouth ulceration—Citalopram—alcohol dependence	0.00302	0.00911	CcSEcCtD
Afatinib—DYRK1A—cerebellum—alcohol dependence	0.00301	0.0102	CbGeAlD
Afatinib—Weight decreased—Naltrexone—alcohol dependence	0.00299	0.00903	CcSEcCtD
Afatinib—LCK—blood—alcohol dependence	0.00298	0.0101	CbGeAlD
Afatinib—Pneumonia—Naltrexone—alcohol dependence	0.00296	0.00895	CcSEcCtD
Afatinib—Infestation—Naltrexone—alcohol dependence	0.00294	0.0089	CcSEcCtD
Afatinib—Infestation NOS—Naltrexone—alcohol dependence	0.00294	0.0089	CcSEcCtD
Afatinib—Epistaxis—Acamprosate—alcohol dependence	0.00294	0.00887	CcSEcCtD
Afatinib—EPHA6—brain—alcohol dependence	0.00293	0.00993	CbGeAlD
Afatinib—Sepsis—Citalopram—alcohol dependence	0.00289	0.00875	CcSEcCtD
Afatinib—Asthenia—Disulfiram—alcohol dependence	0.00289	0.00874	CcSEcCtD
Afatinib—EGFR—testis—alcohol dependence	0.00287	0.00973	CbGeAlD
Afatinib—Conjunctivitis—Naltrexone—alcohol dependence	0.00286	0.00865	CcSEcCtD
Afatinib—Urinary tract infection—Naltrexone—alcohol dependence	0.00286	0.00865	CcSEcCtD
Afatinib—PHKG2—brain—alcohol dependence	0.00282	0.00958	CbGeAlD
Afatinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00278	0.00842	CcSEcCtD
Afatinib—Epistaxis—Naltrexone—alcohol dependence	0.00278	0.00839	CcSEcCtD
Afatinib—EGFR—liver—alcohol dependence	0.00271	0.0092	CbGeAlD
Afatinib—Dizziness—Disulfiram—alcohol dependence	0.00266	0.00805	CcSEcCtD
Afatinib—ABL1—brainstem—alcohol dependence	0.00266	0.00901	CbGeAlD
Afatinib—EGFR—cerebellum—alcohol dependence	0.00265	0.00899	CbGeAlD
Afatinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.0026	0.00785	CcSEcCtD
Afatinib—Rash—Disulfiram—alcohol dependence	0.00254	0.00768	CcSEcCtD
Afatinib—ERBB4—brain—alcohol dependence	0.00254	0.00861	CbGeAlD
Afatinib—ERBB2—brain—alcohol dependence	0.00254	0.00861	CbGeAlD
Afatinib—IRAK1—testis—alcohol dependence	0.00253	0.00859	CbGeAlD
Afatinib—Headache—Disulfiram—alcohol dependence	0.00252	0.00763	CcSEcCtD
Afatinib—Eye disorder—Naltrexone—alcohol dependence	0.00247	0.00747	CcSEcCtD
Afatinib—Alopecia—Acamprosate—alcohol dependence	0.00247	0.00746	CcSEcCtD
Afatinib—LCK—testis—alcohol dependence	0.00247	0.00837	CbGeAlD
Afatinib—Mental disorder—Acamprosate—alcohol dependence	0.00245	0.0074	CcSEcCtD
Afatinib—DYRK1A—brain—alcohol dependence	0.00244	0.00829	CbGeAlD
Afatinib—Malnutrition—Acamprosate—alcohol dependence	0.00243	0.00735	CcSEcCtD
Afatinib—IRAK1—liver—alcohol dependence	0.00239	0.00812	CbGeAlD
Afatinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00238	0.0072	CcSEcCtD
Afatinib—Dysgeusia—Acamprosate—alcohol dependence	0.00238	0.0072	CcSEcCtD
Afatinib—ABL1—adrenal cortex—alcohol dependence	0.00237	0.00806	CbGeAlD
Afatinib—Back pain—Acamprosate—alcohol dependence	0.00235	0.00711	CcSEcCtD
Afatinib—Muscle spasms—Acamprosate—alcohol dependence	0.00234	0.00707	CcSEcCtD
Afatinib—IRAK1—cerebellum—alcohol dependence	0.00234	0.00793	CbGeAlD
Afatinib—Alopecia—Naltrexone—alcohol dependence	0.00234	0.00706	CcSEcCtD
Afatinib—LCK—liver—alcohol dependence	0.00233	0.00792	CbGeAlD
Afatinib—Mental disorder—Naltrexone—alcohol dependence	0.00232	0.007	CcSEcCtD
Afatinib—Malnutrition—Naltrexone—alcohol dependence	0.0023	0.00695	CcSEcCtD
Afatinib—Dysgeusia—Naltrexone—alcohol dependence	0.00225	0.00681	CcSEcCtD
Afatinib—Dehydration—Citalopram—alcohol dependence	0.00225	0.0068	CcSEcCtD
Afatinib—Back pain—Naltrexone—alcohol dependence	0.00223	0.00673	CcSEcCtD
Afatinib—Dry skin—Citalopram—alcohol dependence	0.00222	0.00671	CcSEcCtD
Afatinib—Muscle spasms—Naltrexone—alcohol dependence	0.00221	0.00669	CcSEcCtD
Afatinib—Hypokalaemia—Citalopram—alcohol dependence	0.0022	0.00666	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00218	0.00659	CcSEcCtD
Afatinib—ABL1—cardiovascular system—alcohol dependence	0.00217	0.00735	CbGeAlD
Afatinib—Nasopharyngitis—Citalopram—alcohol dependence	0.00216	0.00654	CcSEcCtD
Afatinib—EGFR—brain—alcohol dependence	0.00215	0.0073	CbGeAlD
Afatinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00214	0.00645	CcSEcCtD
Afatinib—Cough—Acamprosate—alcohol dependence	0.00212	0.00641	CcSEcCtD
Afatinib—ABL1—pancreas—alcohol dependence	0.00211	0.00715	CbGeAlD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00206	0.00621	CcSEcCtD
Afatinib—Cough—Naltrexone—alcohol dependence	0.00201	0.00607	CcSEcCtD
Afatinib—Infection—Acamprosate—alcohol dependence	0.00197	0.00596	CcSEcCtD
Afatinib—ABL1—gonad—alcohol dependence	0.00197	0.00667	CbGeAlD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00195	0.00588	CcSEcCtD
Afatinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00194	0.00588	CcSEcCtD
Afatinib—Skin disorder—Acamprosate—alcohol dependence	0.00193	0.00583	CcSEcCtD
Afatinib—IRAK1—brain—alcohol dependence	0.0019	0.00644	CbGeAlD
Afatinib—Weight decreased—Citalopram—alcohol dependence	0.00189	0.00572	CcSEcCtD
Afatinib—Pneumonia—Citalopram—alcohol dependence	0.00188	0.00567	CcSEcCtD
Afatinib—Infection—Naltrexone—alcohol dependence	0.00187	0.00564	CcSEcCtD
Afatinib—Infestation NOS—Citalopram—alcohol dependence	0.00187	0.00564	CcSEcCtD
Afatinib—Infestation—Citalopram—alcohol dependence	0.00187	0.00564	CcSEcCtD
Afatinib—Nervous system disorder—Naltrexone—alcohol dependence	0.00184	0.00557	CcSEcCtD
Afatinib—Skin disorder—Naltrexone—alcohol dependence	0.00182	0.00551	CcSEcCtD
Afatinib—Stomatitis—Citalopram—alcohol dependence	0.00182	0.0055	CcSEcCtD
Afatinib—Conjunctivitis—Citalopram—alcohol dependence	0.00181	0.00548	CcSEcCtD
Afatinib—Urinary tract infection—Citalopram—alcohol dependence	0.00181	0.00548	CcSEcCtD
Afatinib—ABL1—digestive system—alcohol dependence	0.0018	0.0061	CbGeAlD
Afatinib—Insomnia—Acamprosate—alcohol dependence	0.0018	0.00543	CcSEcCtD
Afatinib—Dyspnoea—Acamprosate—alcohol dependence	0.00177	0.00535	CcSEcCtD
Afatinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.00176	0.00533	CcSEcCtD
Afatinib—Epistaxis—Citalopram—alcohol dependence	0.00176	0.00532	CcSEcCtD
Afatinib—Dyspepsia—Acamprosate—alcohol dependence	0.00175	0.00528	CcSEcCtD
Afatinib—Decreased appetite—Acamprosate—alcohol dependence	0.00173	0.00521	CcSEcCtD
Afatinib—ABL1—blood—alcohol dependence	0.00171	0.00581	CbGeAlD
Afatinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00171	0.00518	CcSEcCtD
Afatinib—Insomnia—Naltrexone—alcohol dependence	0.0017	0.00513	CcSEcCtD
Afatinib—Constipation—Acamprosate—alcohol dependence	0.0017	0.00513	CcSEcCtD
Afatinib—ABL1—midbrain—alcohol dependence	0.00169	0.00574	CbGeAlD
Afatinib—Dyspnoea—Naltrexone—alcohol dependence	0.00167	0.00506	CcSEcCtD
Afatinib—Urinary tract disorder—Citalopram—alcohol dependence	0.00165	0.005	CcSEcCtD
Afatinib—Connective tissue disorder—Citalopram—alcohol dependence	0.00165	0.00497	CcSEcCtD
Afatinib—Urethral disorder—Citalopram—alcohol dependence	0.00164	0.00496	CcSEcCtD
Afatinib—Decreased appetite—Naltrexone—alcohol dependence	0.00163	0.00493	CcSEcCtD
Afatinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00162	0.0049	CcSEcCtD
Afatinib—Fatigue—Naltrexone—alcohol dependence	0.00162	0.00489	CcSEcCtD
Afatinib—Constipation—Naltrexone—alcohol dependence	0.00161	0.00485	CcSEcCtD
Afatinib—Body temperature increased—Acamprosate—alcohol dependence	0.00157	0.00474	CcSEcCtD
Afatinib—Eye disorder—Citalopram—alcohol dependence	0.00157	0.00473	CcSEcCtD
Afatinib—Mediastinal disorder—Citalopram—alcohol dependence	0.00151	0.00456	CcSEcCtD
Afatinib—ABCG2—adrenal cortex—alcohol dependence	0.0015	0.00508	CbGeAlD
Afatinib—ABL1—endocrine gland—alcohol dependence	0.00149	0.00504	CbGeAlD
Afatinib—Body temperature increased—Naltrexone—alcohol dependence	0.00148	0.00449	CcSEcCtD
Afatinib—Alopecia—Citalopram—alcohol dependence	0.00148	0.00447	CcSEcCtD
Afatinib—Mental disorder—Citalopram—alcohol dependence	0.00147	0.00443	CcSEcCtD
Afatinib—Malnutrition—Citalopram—alcohol dependence	0.00146	0.00441	CcSEcCtD
Afatinib—Dysgeusia—Citalopram—alcohol dependence	0.00143	0.00431	CcSEcCtD
Afatinib—Asthenia—Acamprosate—alcohol dependence	0.00142	0.0043	CcSEcCtD
Afatinib—ABL1—testis—alcohol dependence	0.00142	0.00481	CbGeAlD
Afatinib—Back pain—Citalopram—alcohol dependence	0.00141	0.00426	CcSEcCtD
Afatinib—Pruritus—Acamprosate—alcohol dependence	0.0014	0.00424	CcSEcCtD
Afatinib—Muscle spasms—Citalopram—alcohol dependence	0.0014	0.00424	CcSEcCtD
Afatinib—ABL1—nervous system—alcohol dependence	0.00139	0.00472	CbGeAlD
Afatinib—Diarrhoea—Acamprosate—alcohol dependence	0.00136	0.0041	CcSEcCtD
Afatinib—Asthenia—Naltrexone—alcohol dependence	0.00135	0.00407	CcSEcCtD
Afatinib—ABL1—liver—alcohol dependence	0.00134	0.00455	CbGeAlD
Afatinib—ABL1—central nervous system—alcohol dependence	0.00134	0.00454	CbGeAlD
Afatinib—Pruritus—Naltrexone—alcohol dependence	0.00133	0.00402	CcSEcCtD
Afatinib—Dizziness—Acamprosate—alcohol dependence	0.00131	0.00397	CcSEcCtD
Afatinib—ABL1—cerebellum—alcohol dependence	0.00131	0.00444	CbGeAlD
Afatinib—Diarrhoea—Naltrexone—alcohol dependence	0.00128	0.00388	CcSEcCtD
Afatinib—Cough—Citalopram—alcohol dependence	0.00127	0.00384	CcSEcCtD
Afatinib—Vomiting—Acamprosate—alcohol dependence	0.00126	0.00381	CcSEcCtD
Afatinib—Rash—Acamprosate—alcohol dependence	0.00125	0.00378	CcSEcCtD
Afatinib—Dermatitis—Acamprosate—alcohol dependence	0.00125	0.00378	CcSEcCtD
Afatinib—Headache—Acamprosate—alcohol dependence	0.00124	0.00376	CcSEcCtD
Afatinib—Dizziness—Naltrexone—alcohol dependence	0.00124	0.00375	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00123	0.00373	CcSEcCtD
Afatinib—Vomiting—Naltrexone—alcohol dependence	0.00119	0.00361	CcSEcCtD
Afatinib—Rash—Naltrexone—alcohol dependence	0.00118	0.00358	CcSEcCtD
Afatinib—Dermatitis—Naltrexone—alcohol dependence	0.00118	0.00358	CcSEcCtD
Afatinib—Infection—Citalopram—alcohol dependence	0.00118	0.00357	CcSEcCtD
Afatinib—Nausea—Acamprosate—alcohol dependence	0.00118	0.00356	CcSEcCtD
Afatinib—Headache—Naltrexone—alcohol dependence	0.00118	0.00356	CcSEcCtD
Afatinib—Nervous system disorder—Citalopram—alcohol dependence	0.00117	0.00353	CcSEcCtD
Afatinib—Skin disorder—Citalopram—alcohol dependence	0.00116	0.00349	CcSEcCtD
Afatinib—Nausea—Naltrexone—alcohol dependence	0.00112	0.00337	CcSEcCtD
Afatinib—ABCG2—blood—alcohol dependence	0.00108	0.00367	CbGeAlD
Afatinib—Insomnia—Citalopram—alcohol dependence	0.00108	0.00325	CcSEcCtD
Afatinib—ABCG2—midbrain—alcohol dependence	0.00107	0.00362	CbGeAlD
Afatinib—ABL1—brain—alcohol dependence	0.00106	0.00361	CbGeAlD
Afatinib—Dyspnoea—Citalopram—alcohol dependence	0.00106	0.00321	CcSEcCtD
Afatinib—Dyspepsia—Citalopram—alcohol dependence	0.00105	0.00317	CcSEcCtD
Afatinib—Decreased appetite—Citalopram—alcohol dependence	0.00103	0.00313	CcSEcCtD
Afatinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00103	0.0031	CcSEcCtD
Afatinib—Fatigue—Citalopram—alcohol dependence	0.00103	0.0031	CcSEcCtD
Afatinib—Constipation—Citalopram—alcohol dependence	0.00102	0.00308	CcSEcCtD
Afatinib—Body temperature increased—Citalopram—alcohol dependence	0.000941	0.00284	CcSEcCtD
Afatinib—ABCG2—testis—alcohol dependence	0.000894	0.00303	CbGeAlD
Afatinib—Asthenia—Citalopram—alcohol dependence	0.000854	0.00258	CcSEcCtD
Afatinib—ABCG2—liver—alcohol dependence	0.000845	0.00287	CbGeAlD
Afatinib—Pruritus—Citalopram—alcohol dependence	0.000842	0.00254	CcSEcCtD
Afatinib—ABCG2—cerebellum—alcohol dependence	0.000826	0.0028	CbGeAlD
Afatinib—Diarrhoea—Citalopram—alcohol dependence	0.000814	0.00246	CcSEcCtD
Afatinib—ABCB1—forebrain—alcohol dependence	0.000797	0.0027	CbGeAlD
Afatinib—Dizziness—Citalopram—alcohol dependence	0.000787	0.00238	CcSEcCtD
Afatinib—Vomiting—Citalopram—alcohol dependence	0.000757	0.00229	CcSEcCtD
Afatinib—Rash—Citalopram—alcohol dependence	0.00075	0.00227	CcSEcCtD
Afatinib—Dermatitis—Citalopram—alcohol dependence	0.00075	0.00227	CcSEcCtD
Afatinib—Headache—Citalopram—alcohol dependence	0.000745	0.00225	CcSEcCtD
Afatinib—ABCB1—adrenal cortex—alcohol dependence	0.000739	0.00251	CbGeAlD
Afatinib—Nausea—Citalopram—alcohol dependence	0.000707	0.00214	CcSEcCtD
Afatinib—ABCB1—cardiovascular system—alcohol dependence	0.000674	0.00229	CbGeAlD
Afatinib—ABCG2—brain—alcohol dependence	0.000671	0.00228	CbGeAlD
Afatinib—ABCB1—pancreas—alcohol dependence	0.000655	0.00222	CbGeAlD
Afatinib—ABCB1—gonad—alcohol dependence	0.000612	0.00207	CbGeAlD
Afatinib—ABCB1—digestive system—alcohol dependence	0.000559	0.0019	CbGeAlD
Afatinib—ABCB1—blood—alcohol dependence	0.000533	0.00181	CbGeAlD
Afatinib—ABCB1—midbrain—alcohol dependence	0.000526	0.00179	CbGeAlD
Afatinib—ABCB1—endocrine gland—alcohol dependence	0.000462	0.00157	CbGeAlD
Afatinib—ERBB2—Axon guidance—GRIN2B—alcohol dependence	0.000444	0.00426	CbGpPWpGaD
Afatinib—ABCB1—testis—alcohol dependence	0.000441	0.0015	CbGeAlD
Afatinib—ABCG2—HIF-2-alpha transcription factor network—EP300—alcohol dependence	0.000437	0.0042	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—WASF2—alcohol dependence	0.000434	0.00417	CbGpPWpGaD
Afatinib—ABCB1—nervous system—alcohol dependence	0.000433	0.00147	CbGeAlD
Afatinib—EPHA6—Developmental Biology—GRIN2B—alcohol dependence	0.000428	0.00411	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—WASF2—alcohol dependence	0.000428	0.0041	CbGpPWpGaD
Afatinib—ABCB1—liver—alcohol dependence	0.000417	0.00141	CbGeAlD
Afatinib—ABCB1—central nervous system—alcohol dependence	0.000417	0.00141	CbGeAlD
Afatinib—ERBB2—Innate Immune System—WASF1—alcohol dependence	0.000416	0.004	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—WASF1—alcohol dependence	0.00041	0.00394	CbGpPWpGaD
Afatinib—ABCB1—cerebellum—alcohol dependence	0.000407	0.00138	CbGeAlD
Afatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—EP300—alcohol dependence	0.000379	0.00363	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—MAOB—alcohol dependence	0.000378	0.00363	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000368	0.00353	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000368	0.00353	CbGpPWpGaD
Afatinib—ABL1—p53 pathway—EP300—alcohol dependence	0.000353	0.00338	CbGpPWpGaD
Afatinib—ABCB1—brain—alcohol dependence	0.000331	0.00112	CbGeAlD
Afatinib—PHKG2—Disease—GOT2—alcohol dependence	0.000327	0.00313	CbGpPWpGaD
Afatinib—ABL1—Regulation of retinoblastoma protein—EP300—alcohol dependence	0.000322	0.00309	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—ALDH2—alcohol dependence	0.000322	0.00309	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—GRIN2B—alcohol dependence	0.000317	0.00304	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—WASF2—alcohol dependence	0.000314	0.00301	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—WASF1—alcohol dependence	0.000301	0.00289	CbGpPWpGaD
Afatinib—LCK—Notch Signaling Pathway—EP300—alcohol dependence	0.000283	0.00271	CbGpPWpGaD
Afatinib—PHKG2—Disease—GOT1—alcohol dependence	0.000282	0.0027	CbGpPWpGaD
Afatinib—ABL1—p73 transcription factor network—EP300—alcohol dependence	0.000279	0.00268	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—GOT2—alcohol dependence	0.000273	0.00262	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—OPRK1—alcohol dependence	0.000273	0.00262	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—OPRK1—alcohol dependence	0.000269	0.00258	CbGpPWpGaD
Afatinib—ABCG2—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000257	0.00247	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CYP2E1—alcohol dependence	0.000257	0.00247	CbGpPWpGaD
Afatinib—ERBB2—Immune System—WASF2—alcohol dependence	0.000253	0.00243	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—GRIN2B—alcohol dependence	0.000251	0.00241	CbGpPWpGaD
Afatinib—ERBB4—Immune System—WASF2—alcohol dependence	0.000249	0.00239	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000249	0.00239	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—WASF2—alcohol dependence	0.000246	0.00236	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000244	0.00234	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000243	0.00233	CbGpPWpGaD
Afatinib—ERBB2—Immune System—WASF1—alcohol dependence	0.000243	0.00233	CbGpPWpGaD
Afatinib—BLK—Immune System—WASF2—alcohol dependence	0.00024	0.0023	CbGpPWpGaD
Afatinib—ERBB4—Immune System—WASF1—alcohol dependence	0.000239	0.00229	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle, Mitotic—EP300—alcohol dependence	0.000238	0.00228	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—GGT1—alcohol dependence	0.000236	0.00226	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—GOT1—alcohol dependence	0.000236	0.00226	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—WASF1—alcohol dependence	0.000236	0.00226	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—EP300—alcohol dependence	0.000232	0.00222	CbGpPWpGaD
Afatinib—BLK—Immune System—WASF1—alcohol dependence	0.00023	0.0022	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—EP300—alcohol dependence	0.000228	0.00218	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—OPRK1—alcohol dependence	0.000223	0.00214	CbGpPWpGaD
Afatinib—EGFR—Androgen receptor signaling pathway—EP300—alcohol dependence	0.000217	0.00208	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—GRIN2B—alcohol dependence	0.000215	0.00206	CbGpPWpGaD
Afatinib—DYRK1A—Cell Cycle—EP300—alcohol dependence	0.000213	0.00204	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—MAOA—alcohol dependence	0.000212	0.00203	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000211	0.00203	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—WASF2—alcohol dependence	0.00021	0.00201	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—WASF2—alcohol dependence	0.000202	0.00194	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000202	0.00194	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—WASF1—alcohol dependence	0.000201	0.00193	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—OPRK1—alcohol dependence	0.000197	0.00189	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADH6—alcohol dependence	0.000194	0.00187	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—WASF1—alcohol dependence	0.000194	0.00186	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—OPRD1—alcohol dependence	0.000184	0.00176	CbGpPWpGaD
Afatinib—IRAK1—Immune System—WASF2—alcohol dependence	0.000183	0.00175	CbGpPWpGaD
Afatinib—ABL1—Factors involved in megakaryocyte development and platelet production—EP300—alcohol dependence	0.000181	0.00173	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—OPRD1—alcohol dependence	0.000181	0.00173	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—GRIN2B—alcohol dependence	0.000179	0.00172	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PDYN—alcohol dependence	0.000176	0.00169	CbGpPWpGaD
Afatinib—IRAK1—Immune System—WASF1—alcohol dependence	0.000175	0.00168	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PDYN—alcohol dependence	0.000173	0.00166	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000166	0.0016	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—WASF2—alcohol dependence	0.000164	0.00157	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CRHR1—alcohol dependence	0.000164	0.00157	CbGpPWpGaD
Afatinib—ERBB2—Disease—GOT2—alcohol dependence	0.000162	0.00155	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADH1A—alcohol dependence	0.000161	0.00155	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—WASF2—alcohol dependence	0.000161	0.00155	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CRHR1—alcohol dependence	0.000161	0.00155	CbGpPWpGaD
Afatinib—ERBB4—Disease—GOT2—alcohol dependence	0.000159	0.00153	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—WASF1—alcohol dependence	0.000157	0.0015	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—WASF1—alcohol dependence	0.000154	0.00148	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—EP300—alcohol dependence	0.000154	0.00148	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CHRM2—alcohol dependence	0.000154	0.00148	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—GRIN2B—alcohol dependence	0.000153	0.00147	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CHRM2—alcohol dependence	0.000151	0.00145	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—EP300—alcohol dependence	0.000151	0.00145	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—OPRD1—alcohol dependence	0.00015	0.00144	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PDYN—alcohol dependence	0.000144	0.00138	CbGpPWpGaD
Afatinib—ABL1—Immune System—WASF2—alcohol dependence	0.000143	0.00137	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000142	0.00136	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—OPRM1—alcohol dependence	0.000141	0.00135	CbGpPWpGaD
Afatinib—ERBB2—Disease—GOT1—alcohol dependence	0.00014	0.00134	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—OPRM1—alcohol dependence	0.000139	0.00133	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000139	0.00133	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000138	0.00132	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—POMC—alcohol dependence	0.000138	0.00132	CbGpPWpGaD
Afatinib—ERBB4—Disease—GOT1—alcohol dependence	0.000138	0.00132	CbGpPWpGaD
Afatinib—ABL1—Immune System—WASF1—alcohol dependence	0.000137	0.00132	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADH4—alcohol dependence	0.000137	0.00131	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000134	0.00129	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CRHR1—alcohol dependence	0.000134	0.00128	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—OPRD1—alcohol dependence	0.000133	0.00127	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—OPRK1—alcohol dependence	0.000132	0.00127	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NPY—alcohol dependence	0.00013	0.00125	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NPY—alcohol dependence	0.000128	0.00123	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PDYN—alcohol dependence	0.000127	0.00122	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—OPRK1—alcohol dependence	0.000127	0.00122	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CHRM2—alcohol dependence	0.000126	0.00121	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CRH—alcohol dependence	0.000125	0.0012	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR1B—alcohol dependence	0.000125	0.0012	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CRH—alcohol dependence	0.000123	0.00118	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR1B—alcohol dependence	0.000123	0.00118	CbGpPWpGaD
Afatinib—EGFR—Immune System—WASF2—alcohol dependence	0.000122	0.00117	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00012	0.00115	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CRHR1—alcohol dependence	0.000118	0.00113	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—WASF2—alcohol dependence	0.000118	0.00113	CbGpPWpGaD
Afatinib—LCK—Immune System—WASF2—alcohol dependence	0.000118	0.00113	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000118	0.00113	CbGpPWpGaD
Afatinib—EGFR—Immune System—WASF1—alcohol dependence	0.000117	0.00112	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADH7—alcohol dependence	0.000116	0.00112	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—OPRM1—alcohol dependence	0.000116	0.00111	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000114	0.0011	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—EP300—alcohol dependence	0.000114	0.00109	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—WASF1—alcohol dependence	0.000113	0.00109	CbGpPWpGaD
Afatinib—LCK—Immune System—WASF1—alcohol dependence	0.000113	0.00108	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GGT2—alcohol dependence	0.000112	0.00107	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CHRM2—alcohol dependence	0.000111	0.00107	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD4—alcohol dependence	0.00011	0.00105	CbGpPWpGaD
Afatinib—PHKG2—Disease—EP300—alcohol dependence	0.000109	0.00105	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD4—alcohol dependence	0.000108	0.00104	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—NPY—alcohol dependence	0.000106	0.00102	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH6—alcohol dependence	0.000105	0.00101	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CNR1—alcohol dependence	0.000105	0.001	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CNR1—alcohol dependence	0.000103	0.000989	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR1B—alcohol dependence	0.000103	0.000984	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CRH—alcohol dependence	0.000103	0.000984	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ADH1B—alcohol dependence	0.000102	0.00098	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—OPRM1—alcohol dependence	0.000102	0.000979	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—DRD2—alcohol dependence	0.000102	0.000979	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR7—alcohol dependence	0.000102	0.000979	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—EP300—alcohol dependence	0.000101	0.000965	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—DRD2—alcohol dependence	0.000101	0.000965	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR7—alcohol dependence	0.000101	0.000965	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—EP300—alcohol dependence	9.91e-05	0.000951	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	9.9e-05	0.00095	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NPY—alcohol dependence	9.39e-05	0.000901	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—EP300—alcohol dependence	9.14e-05	0.000877	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR1B—alcohol dependence	9.06e-05	0.00087	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CRH—alcohol dependence	9.06e-05	0.00087	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD4—alcohol dependence	8.97e-05	0.00086	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—OPRD1—alcohol dependence	8.87e-05	0.000851	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH1A—alcohol dependence	8.71e-05	0.000836	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AVP—alcohol dependence	8.59e-05	0.000824	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CNR1—alcohol dependence	8.56e-05	0.000821	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—OPRD1—alcohol dependence	8.55e-05	0.00082	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDYN—alcohol dependence	8.51e-05	0.000816	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MAOB—alcohol dependence	8.46e-05	0.000812	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AVP—alcohol dependence	8.46e-05	0.000812	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—DRD2—alcohol dependence	8.35e-05	0.000801	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR7—alcohol dependence	8.35e-05	0.000801	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDYN—alcohol dependence	8.2e-05	0.000786	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD4—alcohol dependence	7.92e-05	0.00076	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CRHR1—alcohol dependence	7.91e-05	0.000759	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—WASF2—alcohol dependence	7.91e-05	0.000759	CbGpPWpGaD
Afatinib—EGFR—Disease—GOT2—alcohol dependence	7.83e-05	0.000751	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CRHR1—alcohol dependence	7.62e-05	0.000731	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—WASF2—alcohol dependence	7.62e-05	0.000731	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—WASF1—alcohol dependence	7.58e-05	0.000727	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CNR1—alcohol dependence	7.56e-05	0.000726	CbGpPWpGaD
Afatinib—LCK—Disease—GOT2—alcohol dependence	7.54e-05	0.000724	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CHRM2—alcohol dependence	7.43e-05	0.000713	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH4—alcohol dependence	7.41e-05	0.000711	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR7—alcohol dependence	7.38e-05	0.000708	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—DRD2—alcohol dependence	7.38e-05	0.000708	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—WASF1—alcohol dependence	7.31e-05	0.000701	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—EP300—alcohol dependence	7.27e-05	0.000698	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALDH2—alcohol dependence	7.2e-05	0.00069	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	7.16e-05	0.000687	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HTR2A—alcohol dependence	7.15e-05	0.000686	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HTR2A—alcohol dependence	7.04e-05	0.000676	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AVP—alcohol dependence	7.03e-05	0.000675	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—OPRM1—alcohol dependence	6.83e-05	0.000655	CbGpPWpGaD
Afatinib—EGFR—Disease—GOT1—alcohol dependence	6.76e-05	0.000648	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	6.58e-05	0.000631	CbGpPWpGaD
Afatinib—LCK—Disease—GOT1—alcohol dependence	6.51e-05	0.000625	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	6.47e-05	0.000621	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—EP300—alcohol dependence	6.44e-05	0.000618	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—EP300—alcohol dependence	6.32e-05	0.000606	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH7—alcohol dependence	6.3e-05	0.000604	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NPY—alcohol dependence	6.28e-05	0.000603	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AVP—alcohol dependence	6.21e-05	0.000596	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT2—alcohol dependence	6.12e-05	0.000587	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR1B—alcohol dependence	6.06e-05	0.000581	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CRH—alcohol dependence	6.06e-05	0.000581	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NPY—alcohol dependence	6.05e-05	0.000581	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT2—alcohol dependence	6.04e-05	0.000579	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	5.94e-05	0.00057	CbGpPWpGaD
Afatinib—ERBB2—Immune System—EP300—alcohol dependence	5.86e-05	0.000562	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HTR2A—alcohol dependence	5.85e-05	0.000561	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	5.84e-05	0.00056	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CRH—alcohol dependence	5.84e-05	0.00056	CbGpPWpGaD
Afatinib—ERBB4—Immune System—EP300—alcohol dependence	5.77e-05	0.000554	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	5.75e-05	0.000552	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—POMC—alcohol dependence	5.71e-05	0.000548	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—EP300—alcohol dependence	5.69e-05	0.000546	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—POMC—alcohol dependence	5.62e-05	0.00054	CbGpPWpGaD
Afatinib—BLK—Immune System—EP300—alcohol dependence	5.55e-05	0.000533	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADH1B—alcohol dependence	5.52e-05	0.00053	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—EP300—alcohol dependence	5.51e-05	0.000528	CbGpPWpGaD
Afatinib—ERBB2—Disease—EP300—alcohol dependence	5.41e-05	0.000519	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	5.35e-05	0.000514	CbGpPWpGaD
Afatinib—ERBB4—Disease—EP300—alcohol dependence	5.33e-05	0.000511	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD4—alcohol dependence	5.3e-05	0.000508	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GGT1—alcohol dependence	5.28e-05	0.000507	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT1—alcohol dependence	5.28e-05	0.000507	CbGpPWpGaD
Afatinib—LCK—Hemostasis—EP300—alcohol dependence	5.21e-05	0.000499	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—alcohol dependence	5.17e-05	0.000496	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD4—alcohol dependence	5.11e-05	0.00049	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CNR1—alcohol dependence	5.06e-05	0.000485	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR7—alcohol dependence	4.94e-05	0.000473	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD2—alcohol dependence	4.94e-05	0.000473	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CNR1—alcohol dependence	4.87e-05	0.000468	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—EP300—alcohol dependence	4.86e-05	0.000467	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR7—alcohol dependence	4.76e-05	0.000456	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD2—alcohol dependence	4.76e-05	0.000456	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MAOA—alcohol dependence	4.73e-05	0.000454	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—EP300—alcohol dependence	4.69e-05	0.00045	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—POMC—alcohol dependence	4.67e-05	0.000448	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOB—alcohol dependence	4.58e-05	0.000439	CbGpPWpGaD
Afatinib—IRAK1—Immune System—EP300—alcohol dependence	4.24e-05	0.000406	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AVP—alcohol dependence	4.15e-05	0.000398	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—POMC—alcohol dependence	4.13e-05	0.000396	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AVP—alcohol dependence	4e-05	0.000384	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALDH2—alcohol dependence	3.89e-05	0.000373	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EP300—alcohol dependence	3.79e-05	0.000363	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EP300—alcohol dependence	3.73e-05	0.000358	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—alcohol dependence	3.46e-05	0.000332	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	3.33e-05	0.00032	CbGpPWpGaD
Afatinib—ABL1—Immune System—EP300—alcohol dependence	3.31e-05	0.000318	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT2—alcohol dependence	3.31e-05	0.000317	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.11e-05	0.000298	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—POMC—alcohol dependence	3.08e-05	0.000296	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT1—alcohol dependence	2.86e-05	0.000274	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT1—alcohol dependence	2.86e-05	0.000274	CbGpPWpGaD
Afatinib—EGFR—Immune System—EP300—alcohol dependence	2.83e-05	0.000272	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—POMC—alcohol dependence	2.76e-05	0.000265	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EP300—alcohol dependence	2.74e-05	0.000263	CbGpPWpGaD
Afatinib—LCK—Immune System—EP300—alcohol dependence	2.73e-05	0.000262	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—POMC—alcohol dependence	2.66e-05	0.000255	CbGpPWpGaD
Afatinib—EGFR—Disease—EP300—alcohol dependence	2.62e-05	0.000251	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOA—alcohol dependence	2.56e-05	0.000246	CbGpPWpGaD
Afatinib—LCK—Disease—EP300—alcohol dependence	2.52e-05	0.000242	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—EP300—alcohol dependence	2.04e-05	0.000196	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EP300—alcohol dependence	1.83e-05	0.000176	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EP300—alcohol dependence	1.76e-05	0.000169	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—POMC—alcohol dependence	1.67e-05	0.00016	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—EP300—alcohol dependence	1.11e-05	0.000106	CbGpPWpGaD
